Campine (CAMB)
Euronext Brussels · Belgium · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 180.00 |
|---|---|
| 52-week range | 168.00 – 260.00 |
| Return, 1 month / 3 months | −2.7% / −14.3% |
| Return, 1 year / 3 years | −25.8% / +195.3% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 41.7% |
| Worst drawdown (1 year) | -30.8% |
| Average daily value traded | 0.09M EUR |
| Dividend yield | 3.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Campine is a Belgian metals and chemicals company based in Beerse. It recovers and refines lead and antimony from recycled materials and process residues, producing lead alloys and antimony products for industrial customers such as battery makers and plastics producers. The company also makes flame retardants and related specialty chemicals. Its business centres on recycling and materials recovery, serving manufacturers that need consistent metal and chemical inputs.
Campine trades under the code CAMB on the Euronext Brussels in Belgium, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Campine (CAMB) trades on the Euronext Brussels in Belgium. It last closed at EUR 180.00 on 23 October 2026.
Its price-based Market X-Ray is 33 out of 100 (a weak price profile), ranking 85 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 25.8% and over the last three months it fell 14.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.1% | ||
| From 52-week high | -30.0% | ||
| Momentum | 22 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.3% | ||
| 6-month return | -14.9% | ||
| 12-month return, skipping the last month | -23.7% | ||
| Stability (higher is calmer) | 30 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.8% | ||
| Liquidity | 47 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.09M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 54 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.9% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.0% |
|---|---|
| 1 month | −2.7% |
| 3 months | −14.3% |
| 6 months | −14.9% |
| 1 year | −25.8% |
| 3 years | +195.3% |
| 5 years | +416.6% |
Signals
| 50-day / 200-day average | 185.28 / 202.36 |
|---|---|
| Golden / death cross (60 days) | Death, 35 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.14 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Jun 2026 | EUR 7.0000 |
| 11 Jun 2025 | EUR 3.1500 |
| 12 Jun 2024 | EUR 2.1000 |
| 7 Jun 2023 | EUR 1.7500 |
| 8 Jun 2022 | EUR 1.9600 |
| 9 Jun 2021 | EUR 0.4550 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.